Our findings in thyroid tumor cells are different from those reported in melanoma, hepatocellular carcinoma (HCC) and colorectal carcinoma (CRC) cells [18], indicating that the actions of the inhibitor on ERK dimerization likely depend on the cell type. The gene discussed is MAPK1; the disease is colorectal carcinoma.